Sex-based multiomics analysis uncovers metabolic and molecular mediators linking MASH and atherosclerosis
Das, Sandeep; Anand, Sumit Kumar; McKinney, M Peyton; Richard, Koral S E; Mahmud, Iqbal; Rohilla, Sumati; Arias, Fabio; Ghrayeb, Alia; Wei, Bo; Tan, Lin; Liu, Zhipeng; Kumar, Dhananjay; Finney, Alexandra C; Pandey, Nilesh; Kaur, Harpreet; Pandit, Rajan; Zhang, Xiaolu; Ben Dhaou, Cyrine; Thayer, Sarah P; Razani, Babak; Cai, Bishuang; Chang, Fei; Schopfer, Francisco J; Liu, Wanqing; Fisher, Edward A; Radhakrishnan, Sridhar; Gottlieb, Eyal; Orr, A Wayne; Dhanesha, Nirav; Yurdagul, Arif; Lorenzi, Philip L; Rom, Oren
BACKGROUND & AIMS/UNASSIGNED:Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in patients with metabolic dysfunction-associated steatohepatitis (MASH). No therapy targets both diseases simultaneously, and a roadblock for discovering new treatments is the lack of animal models that recapitulate both diseases, especially in females. METHODS/UNASSIGNED:mice (n = 8-13) were fed a western diet (WD), modified choline-deficient high-fat diet (mCDHFD), or modified MASH-inducing diet (mMASHD) containing equivalent physiological levels of cholesterol. Comprehensive multiomics including metabolomics, lipidomics, and transcriptomics, alongside histopathological and biochemical analyses, were integrated to characterize concurrent MASH and atherosclerosis. Transcriptomics was validated in other mouse models and integrated with human data (n = 79). RESULTS/UNASSIGNED:0.04). Lipidomic analyses revealed dysregulated polyunsaturated fatty acid, steryl ester, and dihexosylceramide metabolism. Integration of mouse and human transcriptomes revealed similarities in metabolic and proinflammatory/proatherogenic pathways. CONCLUSION/UNASSIGNED:This sex-based multiomics analysis establishes a murine model of concurrent MASH and atherosclerosis, reveals sex-specific dietary responses, and identifies metabolic and transcriptional pathways with potential utility as biomarkers and therapeutic targets. IMPACT AND IMPLICATIONS/UNASSIGNED:mice, we found that different diets containing equivalent physiological levels of cholesterol induce sex-specific responses, with a modified choline-deficient high-fat diet effectively modeling both diseases in both sexes, while a western diet is effective only in males. Multiomics analyses identified key metabolic and inflammatory pathways linking MASH and atherosclerosis that mirror transcriptomic signatures found in humans, and highlight circulating cholesterol, CCL2, and sphinganine as potential biomarkers. These findings establish a translational model and reveal sex-specific metabolic pathways that will advance our understanding of the shared pathophysiology of MASH and atherosclerosis, and facilitate the development of dual therapeutic approaches, addressing an urgent unmet clinical need.
PMCID:12950431
PMID: 41777553
ISSN: 2589-5559
CID: 6008762
The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
Zuberbier, T; Abdul Hameed Ansari, Z; Abdul Latiff, A H; Abuzakouk, M M; Agcaoili-De Jesus, M S; Agondi, R C; Al-Ahmad, M; Alangari, A A; Alhameli, H; Alonso Bello, C D; Alshareef, S; Al-Tamemi, S; Altrichter, S; Al Wahshi, H; Aquilina, S; Araújo, M; Arnaout, R; Asero, R; Ballmer-Weber, B; Bangert, C; Bauer, A; Ben-Shoshan, M; Bernstein, J; Bindslev-Jensen, C; Bizjak, M; Boccon-Gibod, I; Bonnekoh, H; Bouillet, L; Brockow, K; Brzoza, Z; Bulatović Ćalasan, M; Bulkhi, A; Buttgereit, T; Bygum, A; Caballero, T; Calderon, O; Campos, R; Cancian, M; Carne, E; Castor, M A; Cerecedo, I; Çetinarslan, T; Cherrez-Ojeda, I; Chkhikvadze, N; Chong-Neto, H J; Choo, K; Christoff, G; Chu, C-Y; Ciupka, K; Conlon, N; Costa, C; Craig, T; Criado, P; Danilycheva, I; Darlenski, R; De Arruda Chaves, E; de Montjoye, L; Doutre, M S; Du-Thanh, A; Ebo, D; Elkhalifa, S; Elmariah, S; El-Shanawany, T; Ensina, L F; Ertaş, R; Fachini Jardim Criado, R; Ferrer, M; Ferrucci, S; Fok, J S; Fomina, D; Fonacier, L; Fouda, G; Francescantonio, I; Fukunaga, A; Galvan Calle, C A; Garcia, E; Gáspár, K; Gelincik, A; Geng, S; Godse, K; Gonçalo, M; Gotua, M; Grattan, C; Grosber, M; Guidos Fogelbach, G; Guilarte, M; Guillod, R; Hamelmann, E; Hawkes, J; Hayama, K; Heuer, R; Hide, M; Hoetzenecker, W; Inomata, N; Kang, H-R; Kaplan, A; Kapp, A; Karam, M; Kasperska-Zajac, A; Katelaris, C H; Kessel, A; Khoshkhui, M; Kim, B; Kinaciyan, T; Kocatürk, E; Kolacinska-Flont, M; Kolkhir, P; Konstantinou, G N; Kosnik, M; Krasowska, D; Kulthanan, K; Kumaran, M S; Kuprys-Lipinska, I; Labrador, M; Larco, J I; Larenas-Linnemann, D; Latysheva, E; Lazaridou, E; Li, P H; Lima, H; Lippert, U; Magerl, M; Makris, M; Alves Marcelino, J; Marzano, A V; Medina, I; Meshkova, R; Micallef, D; Mohammed Ali, R; Mortz, C G; Munoz, M; Oude Elberink, H N G; Nakonechna, A; Nasr, I; Nast, A; Netchiporouk, E; Nettis, E; Nieto, S; Ogueta Canales, I; Okas, T-L; Orfali, R L; Özkaya, E; Parisi, C; Pennitz, A; Pawankar, R; Pereira, M P; Peter, J; Petkova, E; Pigatto, P D; Podder, I; Popov, T; Porebski, G; Pyatilova, P; Ramon, G D; Ratti Sisa, H A; Recto, M; Ress, K; Ridge, K; Riedl, M; Ritchie, C; Rosario Filho, N; Rosmaninho, I; Rudenko, M; Rukhadze, M; Rutkowski, K; Sabato, V; Sahiner, U M; Saini, S; Saleh Al Sabbagh, F; Salman, A; Salvo, F; Sanchez, J; Santucci, A; Schliemann, S; Schmid-Grendelmeier, P; Sekerel, B E; Serpa, F; Sheikh, F; Sheikh, J; Shendi, H; Siebenhaar, F; Sonomjamts, M; Soria, A; Sousa Pinto, B; Staevska, M; Staubach, P; Stephan, M; Stevanovic, K; Stingeni, L; Stobiecki, M; Su Küçük, Ö; Sussman, G; Szegedi, A; Takahagi, S; Tanaka, A; Teovska Mitrevska, N; Thomsen, S F; Toubi, E; Tsatsou, F; Turk, M; Vadasz, Z; Valerieva, A; Valle, S; Doorn, M V; Veleiro Perez, B; Vera Ayala, C E; Vestergaard, C; Vieira, R J; Maruta, C W; Wedi, B; Werner, R N; Yap, E W Y; Xepapadaki, P; Xiang, Y; Ye, Y-M; Yong, P; Yosipovitch, G; Zalewska-Janowska, A Z J; Zeyen, C; Zhao, Z; Metz, M; Giménez-Arnau, A M
This update and revision of the international guideline for urticaria was developed in accordance with the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is an initiative of the Global Allergy and Asthma Excellence Network (GA2LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), with the participation of 210 delegates from 107 national and international societies, from 59 countries. The consensus conference was held on December 6th, 2024. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, defined by a rapid appearance of wheals, angioedema, or both. The lifetime prevalence of acute urticaria is estimated to be approximately 20%. Chronic urticaria, categorized as either chronic spontaneous urticaria or chronic inducible urticaria, is disabling, impairs quality of life, and affects performance at work and school, however, novel therapies are available. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert-guided and evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.
PMID: 41649409
ISSN: 1398-9995
CID: 6000592